BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31420612)

  • 21. [Safety and efficacy of laparoscopic microwave ablation combined with partial nephrectomy for renal tumors: initial experience].
    Hong BA; Du X; Ji YP; Zhao Q; Wang S; Liu J; Cao YD; Yang X; Du P; Yang Y; Zhang N
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3794-3798. PubMed ID: 34895419
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
    Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.
    Xu H; Xing Z; Ai K; Wang J; Lv Z; Deng H; Li K; Wang Y; Li Y
    World J Surg Oncol; 2024 Jan; 22(1):24. PubMed ID: 38254091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
    Iizuka J; Kondo T; Hashimoto Y; Kobayashi H; Ikezawa E; Takagi T; Omae K; Tanabe K
    Int J Urol; 2012 Nov; 19(11):980-6. PubMed ID: 22735049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy.
    Huang J; Wang Y; Zhang C; Hu X; Wang P; Shi G; Dong L; Zhang J; Kong W; Chen Y; Xia D; Guo J; Xue W; Huang Y; He Z
    Clin Genitourin Cancer; 2023 Apr; 21(2):315.e1-315.e7. PubMed ID: 36396584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
    Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
    Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
    Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
    J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy.
    Lee C; You D; Yoo S; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1651-7. PubMed ID: 27193144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.